Comparison of effects of pravastatin and hormone therapy on soluble P-selectin and platelet P-selectin expression in postmenopausal hypercholesterolemic women.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 16368469)

Published in Maturitas on January 20, 2006

Authors

Roger E Peverill1, Joseph J Smolich, Erica Malan, Rebecca Goldstat, Susan R Davis

Author Affiliations

1: Cardiology Unit, Centre for Heart and Chest Research, Monash University Department of Medicine, Monash Medical Centre, Clayton, Vic., Australia. roger.peverill@med.monash.edu.au

Articles by these authors

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (2013) 7.25

Urinary incontinence in young nulligravid women: a cross-sectional analysis. Ann Intern Med (2012) 3.34

The reservoir-wave paradigm introduces error into arterial wave analysis: a computer modelling and in-vivo study. J Hypertens (2012) 2.52

Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab (2010) 2.27

Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause (2006) 2.07

Incidence of total knee and hip replacement for osteoarthritis in relation to circulating sex steroid hormone concentrations in women. Arthritis Rheumatol (2014) 2.05

Sexual function after breast cancer. J Sex Med (2010) 1.89

Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause (2015) 1.71

Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause (2007) 1.70

Hormone replacement therapy: current controversies. Clin Endocrinol (Oxf) (2003) 1.64

Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause (2003) 1.62

The cross-sectional relationship between fortnightly exercise and knee cartilage properties in healthy adult women in midlife. Menopause (2007) 1.53

Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis. Menopause (2013) 1.41

Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Menopause (2016) 1.38

A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology (2005) 1.36

Treatment of menopausal symptoms: what shall we do now? Lancet (2005) 1.35

Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab (2006) 1.30

New markers for cardiovascular disease risk in women: impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab (2003) 1.27

Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause (2006) 1.09

Wave reflection and central pressure augmentation. J Hypertens (2013) 1.09

Prevalence and incidence of urinary incontinence in women: review of the literature and investigation of methodological issues. Int J Urol (2008) 1.06

The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples. Thromb Haemost (2013) 1.06

Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) (2007) 1.06

Sexual function in well women: stratification by sexual satisfaction, hormone use, and menopause status. J Sex Med (2008) 1.05

Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab (2014) 1.02

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psychoneuroendocrinology (2010) 1.02

Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J (2002) 1.00

Age-specific prevalence of, and factors associated with, different types of urinary incontinence in community-dwelling Australian women assessed with a validated questionnaire. Maturitas (2009) 1.00

Adipose aromatase gene expression is greater in older women and is unaffected by postmenopausal estrogen therapy. Menopause (2005) 0.99

Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev (2004) 0.99

Total cholesterol and triglycerides are associated with the development of new bone marrow lesions in asymptomatic middle-aged women - a prospective cohort study. Arthritis Res Ther (2009) 0.98

Lack of the antioxidant glutathione peroxidase-1 does not increase atherosclerosis in C57BL/J6 mice fed a high-fat diet. J Lipid Res (2006) 0.95

Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence. J Sex Med (2012) 0.95

Compartment differences in knee cartilage volume in healthy adults. J Rheumatol (2002) 0.95

DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update (2007) 0.94

Urinary incontinence is associated with lower psychological general well-being in community-dwelling women. Menopause (2010) 0.93

Differential expression of factors involved in fat metabolism with age and the menopause transition. Maturitas (2005) 0.92

Aortic wave intensity analysis of ventricular-vascular interaction during incremental dobutamine infusion in adult sheep. Am J Physiol Heart Circ Physiol (2007) 0.92

Static knee alignment is associated with the risk of unicompartmental knee cartilage defects. J Orthop Res (2008) 0.91

Endocrine aspects of women's sexual function. J Sex Med (2010) 0.90

High sensitivity C-reactive protein is associated with lower tibial cartilage volume but not lower patella cartilage volume in healthy women at mid-life. Arthritis Res Ther (2008) 0.89

Greater superior than inferior parietal lobule activation with increasing rotation angle during mental rotation: an fMRI study. Neuropsychologia (2009) 0.89

Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy. Proc Natl Acad Sci U S A (2012) 0.88

Understanding discontinuation of oral adjuvant endocrine therapy by women with hormone receptor-positive invasive breast cancer nearly 4 years from diagnosis. Menopause (2013) 0.87

The ebbing tide of the reservoir-wave model. J Hypertens (2015) 0.87

Scalability and in vivo validation of a multiscale numerical model of the left coronary circulation. Am J Physiol Heart Circ Physiol (2013) 0.86

Negative beliefs about low back pain are associated with high pain intensity and high level disability in community-based women. BMC Musculoskelet Disord (2008) 0.86

The natural history of bone marrow lesions in community-based middle-aged women without clinical knee osteoarthritis. Semin Arthritis Rheum (2008) 0.86

Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women. J Womens Health (Larchmt) (2008) 0.86

The safety of 52 weeks of oral DHEA therapy for postmenopausal women. Maturitas (2009) 0.86

Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome. Pediatr Res (2010) 0.85

Prevalence of fecal incontinence and its relationship with urinary incontinence in women living in the community. Menopause (2011) 0.85

Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas (2011) 0.85

A pragmatic approach to the classification of menopausal status for community-based research. Menopause (2008) 0.85

Testosterone insufficiency in women: fact or fiction? World J Urol (2002) 0.84

Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40-65 years. Med J Aust (2015) 0.84

Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC Cancer (2008) 0.84

Low back pain and disability in community-based women: prevalence and associated factors. Menopause (2009) 0.83

The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer. Fam Cancer (2009) 0.83

DHEA for postmenopausal women: a review of the evidence. Maturitas (2010) 0.83

Determinants of change in patella cartilage volume in healthy subjects. J Rheumatol (2006) 0.82

Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med (2008) 0.82

Androgens in women. J Steroid Biochem Mol Biol (2003) 0.82

The relationship between the knee adduction moment and knee pain in middle-aged women without radiographic osteoarthritis. J Rheumatol (2006) 0.82

Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause (2013) 0.82

The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice. Australas J Ageing (2011) 0.81

A decontamination and sterilization protocol employed during reuse of cardiac electrophysiology catheters inactivates human immunodeficiency virus. Infect Control Hosp Epidemiol (2003) 0.81

Lymphedema: experience of a cohort of women with breast cancer followed for 4 years after diagnosis in Victoria, Australia. Support Care Cancer (2013) 0.81

The associations between the dominant and nondominant peak external knee adductor moments during gait in healthy subjects: evidence for symmetry. Arch Phys Med Rehabil (2009) 0.81

Androgenic hormones and aging--the link with female sexual function. Horm Behav (2011) 0.81

Breast cancer survivors' beliefs about the causes of breast cancer. Psychooncology (2011) 0.81

Osteoarthritis and the postmenopausal woman: Epidemiological, magnetic resonance imaging, and radiological findings. Semin Arthritis Rheum (2004) 0.81

Non-linear separation of pressure, velocity and wave intensity into forward and backward components. Med Biol Eng Comput (2012) 0.81

Postmenopausal testosterone therapy and breast cancer risk. Maturitas (2004) 0.81

What is the rationale for androgen therapy for women? Treat Endocrinol (2003) 0.81

Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (2006) 0.80

What is the clinical and ethical importance of incidental abnormalities found by knee MRI? Arthritis Res Ther (2008) 0.80

Validity and cultural equivalence of the standard Greene Climacteric Scale in Hong Kong. Menopause (2010) 0.80

Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial. J Sex Med (2014) 0.79

Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer. J Womens Health (Larchmt) (2009) 0.79

One-dimensional haemodynamic modeling and wave dynamics in the entire adult circulation. Ann Biomed Eng (2015) 0.79

Association between meniscal tears and the peak external knee adduction moment and foot rotation during level walking in postmenopausal women without knee osteoarthritis: a cross-sectional study. Arthritis Res Ther (2008) 0.79

Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv (2013) 0.79

Rivaroxaban and false positive lupus anticoagulant testing. Thromb Haemost (2010) 0.78

Continuous-combined oral estradiol/drospirenone has no detrimental effect on cognitive performance and improves estrogen deficiency symptoms in early postmenopausal women: a randomized placebo-controlled trial. Menopause (2013) 0.78

Testosterone improves verbal learning and memory in postmenopausal women: Results from a pilot study. Maturitas (2011) 0.78

Incidence and resolution rates of different types of urinary incontinence in women: findings from a cohort study. J Urol (2011) 0.78

Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) (2007) 0.78

An update on the pharmacological management of female sexual dysfunction. Expert Opin Pharmacother (2012) 0.78

The role of androgen therapy. Best Pract Res Clin Obstet Gynaecol (2002) 0.78

Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial. Menopause (2006) 0.78

Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women. J Clin Endocrinol Metab (2005) 0.78

Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis. Menopause (2013) 0.78

Determining the effects of androgen therapy on sexual well-being: a complex challenge. Menopause (2005) 0.77

A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. J Sex Med (2009) 0.77

Robustness of the P-U and lnD-U loop wave speed estimation methods: effects of the diastolic pressure decay and vessel wall non-linearities. Conf Proc IEEE Eng Med Biol Soc (2011) 0.77

Changes in patterns of use of cigarettes and alcohol in women after a first diagnosis of invasive breast cancer: a cohort study of women from Victoria, Australia. Support Care Cancer (2011) 0.77

Androgen replacement therapy in androgen-deficient women with hypopituitarism. Drugs (2008) 0.77